Suchergebnisse - "Gentile, Massimo"

PubPharm (459)

81

Comparison of two scores in predicting pulmonary embolism-related adverse events in intermediate–high-risk patients: a systematic review and meta-analysis

enthalten in: Internal and emergency medicine | 2022

von Bova, C. | Vigna, E. | Gentile, M. | +1

82

Comparison of two scores in predicting pulmonary embolism-related adverse events in intermediate–high-risk patients: a systematic review and meta-analysis

enthalten in: Internal and emergency medicine | 2022

von Bova, C. | Vigna, E. | Gentile, M. | +1

83

Unmutated IGHV1-69 CLL Clone Displays a Distinct Gene Expression Profile by a Comparative qRT-PCR Assay

enthalten in: Biomedicines | 2022

von Mimmi, S. | Maisano, D. | Dattilo, V. | +10

84

Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia : A real-life campus CLL study

enthalten in: American journal of hematology | 2022

von Visentin, A. | Mauro, F. | Cibien, F. | +20

85

A novel phage display based platform for exosome diversity characterization

enthalten in: Nanoscale | 2022

von Maisano, D. | Mimmi, S. | Dattilo, V. | +17

86

A Case of Immune Thrombocytopenia After COVID-19 Vaccination: Coincidental or Causal Effect? Running Title: ITP After COVID-19 Vaccination

enthalten in: ResearchSquare.com | 2022

von Vigna, E. | Caracciolo, D. | Martino, E. | +5

87

Mitochondrial Determinants of Anti-Cancer Drug-Induced Cardiotoxicity

enthalten in: Biomedicines | 2022

von Rocca, C. | De Francesco, E. | Pasqua, T. | +9

88

LINC00152 expression in normal and Chronic Lymphocytic Leukemia B cells

enthalten in: Hematological oncology | 2022

von Matis, S. | Rossi, M. | Brondolo, L. | +16

89

Italian patients with hemoglobinopathies exhibit a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infection

enthalten in: American journal of hematology | 2022

von Longo, F. | Gianesin, B. | Voi, V. | +51

90

Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions : A real-life CLL campus study

enthalten in: Frontiers in oncology | 2022

von Visentin, A. | Mauro, F. | Catania, G. | +24